Cinta Hierro - Publications

Zanidatamab with and without Tislelizumab in HER2-Positive Gastroesophageal Cancer.

Journal: The New England journal of medicine

Published: May 27, 2026

Targeting claudins in gastric cancer: A novel GLOWing strategy in the SPOTLIGHT.

Journal: Cancer treatment reviews

Published: February 24, 2026

Biomarker-guided immunotherapy in gastric cancer: current insights and future perspectives.

Journal: Cancer treatment reviews

Published: February 06, 2026

Application of a translational research platform to unveil efficacy signals and mechanisms of resistance of FGFR inhibitors in multiple FGFR-altered solid tumors.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 27, 2026

Implementing a molecular prescreening strategy for tumors without public NGS access in a cancer center network: Results from the PREICO project.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 11, 2026

Real-world characterization of PD-L1 expression in patients with advanced esophagogastric adenocarcinoma in Spain.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: December 19, 2025

Claudin 18.2 expression in gastroesophageal adenocarcinoma: biomarker overlap and association with clinical outcomes in a European cohort.

Journal: ESMO open

Published: October 31, 2025

KRAS-targeted therapies in colorectal cancer: a systematic analysis of mutations, inhibitors, and clinical trials.

Journal: NPJ precision oncology

Published: July 07, 2025

Does perioperative FLOT increase cure rates in resectable esophageal adenocarcinoma? A mixture cure model analysis.

Journal: British journal of cancer

Published: June 25, 2025

Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trial.

Journal: ESMO open

Published: June 16, 2025

Cabozantinib plus Atezolizumab in Advanced, Progressive Endocrine Malignancies: A Multicohort, Basket, Phase II Trial (CABATEN/GETNE-T1914).

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 06, 2025

Optimal timing for initiating first-line palliative systemic therapy in asymptomatic metastatic esophagogastric cancer: Insights from a European Delphi study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: October 03, 2024